In conclusion, our meta-analysis suggested that DNMT3B −149C/T polymorphism was not related to overall cancer risk, whereas there was an association between DNMT3B −149C/T polymorphism and head and neck cancer risk under heterozygote comparison and dominant model. This evidence concerns the gene DNMT3B and cancer.